Implications of tumour heterogeneity on cancer evolution and therapy resistance: lessons from breast cancer
The Journal of Pathology · 2023-08 · 260 (5) · 621-636
DOI: 10.1002/path.6158 ↗At a glance
Übersichtsarbeit in The Journal of Pathology, published online on 2023-08-16. Written by Shefali Thakur and 2 co-authors. Institution: The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. Major MEDLINE topics: Neoplasms. Cited 14 times so far (Crossref); 181 references. Funded by: Breast Cancer Now.
Abstract (original language)
Tumour heterogeneity is pervasive amongst many cancers and leads to disease progression, and therapy resistance. In this review, using breast cancer as an exemplar, we focus on the recent advances in understanding the interplay between tumour cells and their microenvironment using single cell sequencing and digital spatial profiling technologies. Further, we discuss the utility of lineage tracing methodologies in pre‐clinical models of breast cancer, and how these are being used to unravel new therapeutic vulnerabilities and reveal biomarkers of breast cancer progression. © 2023 The Pathological Society of Great Britain and Ireland.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
ORCID profiles: Shefali Thakur, Rachael Natrajan
Funding
- Breast Cancer Now
Cite
APA
Thakur, S., Haider, S., & Natrajan, R. (2023). Implications of tumour heterogeneity on cancer evolution and therapy resistance: lessons from breast cancer. The Journal of Pathology, 260(5), 621-636. https://doi.org/10.1002/path.6158
Vancouver
Thakur S, Haider S, Natrajan R. Implications of tumour heterogeneity on cancer evolution and therapy resistance: lessons from breast cancer. The Journal of Pathology. 2023;260(5):621-636. doi:10.1002/path.6158
BibTeX
@article{Thakur2023,
author = {Thakur, Shefali and Haider, Syed and Natrajan, Rachael},
title = {Implications of tumour heterogeneity on cancer evolution and therapy resistance: lessons from breast cancer},
journal = {The Journal of Pathology},
year = {2023},
volume = {260},
number = {5},
pages = {621--636},
doi = {10.1002/path.6158}
}
EUVIMED